NEW YORK (GenomeWeb News) – SQI Diagnostics' fiscal first quarter revenues declined 25 percent year over year, the company reported after the close of the market on Thursday.

For the three months ended Dec. 31, 2012, revenues dropped to C$3,000 (US$2,980) from C$4,000 a year ago, the Toronto-based company said in a document filed with Canadian regulators. All revenues derived from product sales.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: multiplex genotyping of germline and somatic short tandem repeats, graph-based regularization, and more.

A lack of funding may lead more than two dozen research facilities in Australia to shut down in three months.

Researchers report that paternally inherited genes are more likely to be expressed in mice.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.